--- title: "Ion Beam Applications S.A. Recalls: Agency-Reported Status and History (Oct 1, 2026) | Is It on Recall" description: "Search Ion Beam Applications S.A. recall records, lots, firms and dates. Reported status can be incomplete; use the linked agency notice for current instructions." url: https://isitonrecall.com/brand/ion-beam-applications-s-a/ updated: 2026-10-01 site: "Is It on Recall" language: en --- [Home](https://isitonrecall.com/) / Brand archive # Ion Beam Applications S.A. recall records **8** reported ongoing 9 records in this archive. Latest source date Feb 3, 2026. FDA enforcement status can lag behind the recall lifecycle. An empty search or a reported termination is not a personal product-safety determination. Archive changed Oct 1, 2026. USDA FSIS records are unavailable; [check FSIS directly](https://www.fsis.usda.gov/recalls). [Source coverage and dates](https://isitonrecall.com/sources/). ## Records and reported status Feb 3, 2026 FDA device enforcement ### [IBA Proton Therapy System - PROTEUS 235](https://isitonrecall.com/recall/fda-device-z-1497-2026-iba-proton-therapy-system-proteus-235/) It was identified that eh Universal Beam Triggering Interface (UBTI) is disabled in the Therapy Safety System (TSS) configuration. In this condition, the TSS does not interrupt the beam delivery if the Healthy Signal from an external gating device is lost. ... Class II Reported ongoing Distribution: Worldwide - US Nationwide distribution in the state of FL and the countries of Italy and Japan. [Official source for IBA Proton Therapy System - PROTEUS 235](https://api.fda.gov/device/enforcement.json?search=recall_number%3A%22Z-1497-2026%22) Jul 10, 2024 FDA device enforcement ### [IBA Proton Therapy System - PROTEUS 235- Designed to produce and deliver a proton beam for the treatment of patients with localized tumors and other conditions susceptible to tr...](https://isitonrecall.com/recall/fda-device-z-2693-2024-iba-proton-therapy-system-proteus-235-designed-to-produce-and-deliver-a-proton-beam-for-the-treatmen/) Temporary deactivation of collision detection for Forte Robotic Patient Positioning System occasionally experiences issues Class II Reported ongoing Distribution: IL,LA, NJ, MI,OK, TN, TX, VA, WA Foreign: Czech Republic France Germany Italy Japan Poland Russia Sweden [Official source for IBA Proton Therapy System - PROTEUS 235- Designed to produce and deliver a proton beam for the tr...](https://api.fda.gov/device/enforcement.json?search=recall_number%3A%22Z-2693-2024%22) Jul 8, 2024 FDA device enforcement ### [IBA Proton Therapy System - PROTEUS 235 ProteusPLUS and ProteusONE Software versions: PTS-8 versions, PTS-10 versions, PTS-11 versions, and PTS-12 versions](https://isitonrecall.com/recall/fda-device-z-3089-2024-iba-proton-therapy-system-proteus-235-proteusplus-and-proteusone-software-versions-pts-8-versions-pt/) Safety Parameters Verification Mechanisms can be deactivated in clinical runtime Class II Reported ongoing Distribution: Worldwide - US Nationwide distribution in the states of AK, NJ, PA, VA,OK,FL, KA, IL, LA, MI, TN , TX, VA and the countries of BE, CZ, DE, ES, FR, IN, IT, JP, NL, PL, RU, SE, SG... [Official source for IBA Proton Therapy System - PROTEUS 235 ProteusPLUS and ProteusONE Software versions: PTS-8 versi...](https://api.fda.gov/device/enforcement.json?search=recall_number%3A%22Z-3089-2024%22) May 10, 2024 FDA device enforcement ### [IBA Proton Therapy System - PROTEUS 235 - Designed to produce and deliver a proton beam for the treatment of patients with localized tumors and other conditions susceptible to t...](https://isitonrecall.com/recall/fda-device-z-1945-2024-iba-proton-therapy-system-proteus-235-designed-to-produce-and-deliver-a-proton-beam-for-the-treatmen/) Irradiation is not interrupted when some C230 Accelerator Control Unit critical parameters are outside of the defined tolerances Class II Reported ongoing Distribution: Worldwide - US Nationwide distribution in the state of Virginia and the country of India. [Official source for IBA Proton Therapy System - PROTEUS 235 - Designed to produce and deliver a proton beam for the t...](https://api.fda.gov/device/enforcement.json?search=recall_number%3A%22Z-1945-2024%22) Mar 4, 2024 FDA device enforcement ### [IBA Proton Therapy System - PROTEUS 235, PTS-10 versions, PTS-11 versions, and PTS-12 versions.](https://isitonrecall.com/recall/fda-device-z-1603-2024-iba-proton-therapy-system-proteus-235-pts-10-versions-pts-11-versions-and-pts-12-versions/) There is a risk of mistreatment as irradiation is not prevented when some safety parameters are out of tolerance. Class II Reported ongoing Distribution: US Nationwide distribution in the states of AR, FL, LA, KS, MI, TX, VA. [Official source for IBA Proton Therapy System - PROTEUS 235, PTS-10 versions, PTS-11 versions, and PTS-12 versions.](https://api.fda.gov/device/enforcement.json?search=recall_number%3A%22Z-1603-2024%22) Sep 18, 2023 FDA device enforcement ### [IBA Proton Therapy System - PROTEUS 235. PTS-11 versions, PTS-12 versions with Orion PPS version OSS6.0. Configured with Orion Patient Positioning System.](https://isitonrecall.com/recall/fda-device-z-0295-2024-iba-proton-therapy-system-proteus-235-pts-11-versions-pts-12-versions-with-orion-pps-version-oss6-0/) The patient positioning system can perform motions in unexpected directions, creating the potential for crushing of the patient between the patient positioning devices. Class II Reported ongoing Distribution: Worldwide - US Nationwide distribution in the states of Arkansas, Florida, Kansas, and Virginia and the countries of Belgium, France, India, Italy, Netherlands, Spain, Singapore... [Official source for IBA Proton Therapy System - PROTEUS 235. PTS-11 versions, PTS-12 versions with Orion PPS version ...](https://api.fda.gov/device/enforcement.json?search=recall_number%3A%22Z-0295-2024%22) Apr 20, 2022 FDA device enforcement ### [Proteus235- Proton Therapy System: to produce and deliver a proton beam for the treatment of patients with localized tumors and other conditions susceptible to treatment by radi...](https://isitonrecall.com/recall/fda-device-z-1205-2022-proteus235-proton-therapy-system-to-produce-and-deliver-a-proton-beam-for-the-treatment-of-patients/) First layer of Uniform Scanning treatment fields is sometimes irradiated with incorrect Scanning Magnet setpoints resulting in the field size may be smaller than expected and the irradiated area may receive more dose than prescribed Class II Reported ongoing Distribution: Worldwide distribution - US Nationwide distribution in the states of IL, VA, WA and the country of Germany. [Official source for Proteus235- Proton Therapy System: to produce and deliver a proton beam for the treatment of pati...](https://api.fda.gov/device/enforcement.json?search=recall_number%3A%22Z-1205-2022%22) Feb 15, 2022 FDA device enforcement ### [ProteusPLUS and ProteusONE- designed to produce and deliver a proton beam for the treatment of patients with localized tumors and other conditions susceptible to treatment by ra...](https://isitonrecall.com/recall/fda-device-z-0747-2022-proteusplus-and-proteusone-designed-to-produce-and-deliver-a-proton-beam-for-the-treatment-of-patien/) When resuming from a beam pause, the Proton Therapy System does not verify whether the beam range has not been manually modified during the pause and is still the prescribed one. Therefore, if an operator manually modified the range during a pause, there is... Class II Reported ongoing Distribution: IL, KS, LA, FL, MI, OK, PA, NJ, TN, TX, VA, WA Foreign: Belgium, England, Germany, France, Czech Republic, Italy, Poland, Russia, Spain, Sweden, South Korea, Taiwan, Netherlands, [Official source for ProteusPLUS and ProteusONE- designed to produce and deliver a proton beam for the treatment of pa...](https://api.fda.gov/device/enforcement.json?search=recall_number%3A%22Z-0747-2022%22) Nov 29, 2021 FDA device enforcement ### [Proteus 235; Version: PTS-8 versions before PTS-8.7.2](https://isitonrecall.com/recall/fda-device-z-0466-2022-proteus-235-version-pts-8-versions-before-pts-8-7-2/) Proton Therapy System (PTS) software can be started in the clinical environment (clinical user) while some processes are still running in the test environment (tcs user). Initiating the startup of the clinical processes in the environment is not prevented e... Class II Reported terminated Distribution: IN USA: VA, OK, NJ, TN OUS: Czech Republic. [Official source for Proteus 235; Version: PTS-8 versions before PTS-8.7.2](https://api.fda.gov/device/enforcement.json?search=recall_number%3A%22Z-0466-2022%22) ## Reasons in these listed records - It was identified that eh Universal Beam Triggering Interface (UBTI) is disabled in the Therapy Safety System (TSS) configuration. In this condition, the TSS does not interrupt the beam delivery if the Healthy Signal from an external gating device is lost. This may lead to a r... - Temporary deactivation of collision detection for Forte Robotic Patient Positioning System occasionally experiences issues - Safety Parameters Verification Mechanisms can be deactivated in clinical runtime - Irradiation is not interrupted when some C230 Accelerator Control Unit critical parameters are outside of the defined tolerances These examples come from this result page and are not a ranking of every recall reason. ## Checking Ion Beam Applications S.A. ### Is there a recall on ion beam applications s.a. right now? This archive contains 9 records, including 8 with agency-reported ongoing status. The status field can be incomplete or stale. Open the current official notice and match your exact product. ### How do I check my package or product? Compare the product, firm and lot, date, model or serial identifiers with the notice. [Use the label-check guide](https://isitonrecall.com/guides/read-lot-codes/) if you need help locating an identifier. ### Does a matching name mean every item is included? A name is a search match. The agency notice sets the affected products and identifiers. Do not assume that every item with the same name or brand belongs to the recall. ### What if the search finds no matching record? This search has source and keyword limits. Missing records or a missing lot code do not establish that a product is unaffected. [Check source coverage](https://isitonrecall.com/sources/) and the agency's current notices. ### Where can I find older records? Use [monthly archives](https://isitonrecall.com/archives/) or the local search. The initial import covers records dated from October 2021 where available; each source's actual first and latest dates appear on the coverage page. ## Keep checking [Search Ion Beam Applications S.A.](https://isitonrecall.com/check/?q=Ion%20Beam%20Applications%20S.A.) [Browse related products](https://isitonrecall.com/products/) [Review source dates](https://isitonrecall.com/sources/)